Clinical Trial Record

Return to Clinical Trials

Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders


2000-10-01


2025-12-30


2025-12-30


12000

Study Overview

Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

RATIONALE: Gathering medical information and collecting and storing samples of blood and tissue to test in the laboratory may help doctors develop better ways to screen people at risk for pancreatic cancer or other pancreatic disorders in the future. PURPOSE: This clinical trial is collecting medical information and tissue samples from patients with pancreatic cancer or other pancreatic disorders.

PRIMARY OBJECTIVE: I. To maintain a resource (bank) of biospecimens and data collected from individuals being seen clinically for pancreas conditions to facilitate the discovery and development of (but not limited to) biomarkers of risk (including genomic and proteomic) and early detection as well as novel targeted therapies for pancreatic diseases with a focus on pancreatic cancer. OUTLINE: This is an observational study. Patients undergo blood, saliva, and previously obtained leftover tissue sample collection on study. Patients also complete questionnaires and have their medical records reviewed on study.

  • Islet Cell Tumor
  • Pancreatic Cancer
  • Pancreatic Disease
  • Acute Pancreatitis
  • Chronic Pancreatitis
  • Hereditary Pancreatitis
  • Pancreatic Neuroendocrine Carcinoma
  • OTHER: medical chart review
  • OTHER: survey administration
  • OTHER: biospecimen collection
  • 354-06
  • P50CA102701-08 (U.S. NIH Grant/Contract)
  • CDR0000613100 (OTHER Identifier) (OTHER: NCI)

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2009-01-27  

N/A  

2025-01-24  

2009-01-27  

N/A  

2025-01-28  

2009-01-28  

N/A  

2025-01  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
N/A


Allocation:
N/A


Interventional Model:
N/A


Masking:
N/A


Arms and Interventions

Participant Group/ArmIntervention/Treatment
: Observational

Patients undergo blood, saliva, and previously obtained leftover tissue sample collection on study. Patients also complete questionnaires and have their medical records reviewed on study.

OTHER: medical chart review

  • baseline, 12 month and 36 months

OTHER: survey administration

  • baseline, 6 month, 12 month

OTHER: biospecimen collection

  • baseline
Primary Outcome MeasuresMeasure DescriptionTime Frame
Collection of clinical data, health and family histories by surveybaseline enrollment, 6 months, 12 months
Collection of blood and/or tissue, fecal and oral specimensbaseline
Collection of information regarding food preparation and intake by surveybaseline
Secondary Outcome MeasuresMeasure DescriptionTime Frame

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Name: Adriana Delgado, MA

Phone Number: 1-800-914-7962

Email: pancreas@mayo.edu

Study Contact Backup

Name: Heather M Streich, CCRP

Phone Number: 1-800-914-7962

Email: pancreas@mayo.edu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:


  • Known or suspected pancreas disease including:


  • pancreas adenocarcinoma
  • islet cell cancer
  • pancreatic cysts
  • pancreatitis (hereditary, acute, or chronic)
  • Next of kin of deceased participant who did not complete participation before passing away

  • Exclusion Criteria:

  • Under the age of 18
  • Unable to provide informed consent
  • Prison inmates

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

  • National Cancer Institute (NCI)

  • PRINCIPAL_INVESTIGATOR: Shounak Majumder, MD, Mayo Clinic

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

No publications available